The tumor spheroid assay showed that PRKCSH depletion (shPRK) in A549 cells increased the sensitivity to NK-92 cell-mediated cytotoxicity compared to that in the control group (shCon) (Fig. 1f). This evidence concerns the gene PRKCSH and neoplasm.